TAKEDAMEDCONNECT.COM: Keyword Density Checker

Total words: 2317 | 2-word phrases: 601 | 3-word phrases: 658 | 4-word phrases: 683

PAGE INFO

Title	Try to keep the title under 60 characters (19 characters) Takeda U.S. Medical
Description	Try to keep the meta description between 50 - 160 characters (128 characters) Professional resource for clinical and scientific information for healthcare professionals on Takeda U.S. products and programs.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

ONE WORD PHRASES 375 Words

#	Keyword	Frequency	Density
1	human	24	6.40%
2	a	23	6.13%
3	the	21	5.60%
4	and	20	5.33%
5	product	19	5.07%
6	takeda	18	4.80%
7	us	17	4.53%
8	to	17	4.53%
9	of	14	3.73%
10	factor	14	3.73%

TWO WORD PHRASES 601 Words

#	Keyword	Frequency	Density
1	the us	9	1.50%
2	of a	8	1.33%
3	a product	8	1.33%
4	immune globulin	8	1.33%
5	antihemophilic factor	8	1.33%
6	factor recombinant	8	1.33%
7	in a	6	1.00%
8	inhibitor human	6	1.00%
9	5 solution	6	1.00%
10	us medical	6	1.00%
11	healthcare professional	6	1.00%
12	medical a	5	0.83%
13	metformin hcl	4	0.67%
14	the approved	4	0.67%
15	select a	4	0.67%
16	beyond the	4	0.67%
17	product beyond	4	0.67%
18	takeda product	4	0.67%
19	alogliptin and	4	0.67%
20	pioglitazone and	4	0.67%

THREE WORD PHRASES 658 Words

#	Keyword	Frequency	Density
1	immune globulin infusion	4	0.61%
2	singleentity amphetamine product	4	0.61%
3	product beyond the	4	0.61%
4	beyond the approved	4	0.61%
5	takeda product beyond	4	0.61%
6	us medical a	4	0.61%
7	5 albumin human	4	0.61%
8	albumin human usp	4	0.61%
9	alpha1proteinase inhibitor human	4	0.61%
10	mixed salts of	4	0.61%
11	salts of a	4	0.61%
12	select a product	4	0.61%
13	amphetamine product cii	4	0.61%
14	antihemophilic factor recombinant	4	0.61%
15	report an adverse	3	0.46%
16	adverse event or	3	0.46%
17	event or product	3	0.46%
18	or product quality	3	0.46%
19	product quality complaint	3	0.46%
20	site is intended	3	0.46%
21	an adverse event	3	0.46%
22	this site is	3	0.46%
23	the approved labeling	3	0.46%
24	diseases and conditions	3	0.46%
25	please separate keywords	2	0.30%
26	eohilia™ budesonide oral	2	0.30%
27	vedolizumab eohilia™ budesonide	2	0.30%
28	separate keywords with	2	0.30%
29	entyvio® vedolizumab eohilia™	2	0.30%
30	idursulfase entyvio® vedolizumab	2	0.30%

FOUR WORD PHRASES 683 Words

#	Keyword	Frequency	Density
1	singleentity amphetamine product cii	4	0.59%
2	mixed salts of a	4	0.59%
3	product beyond the approved	4	0.59%
4	takeda product beyond the	4	0.59%
5	5 albumin human usp	4	0.59%
6	adverse event or product	3	0.44%
7	this site is intended	3	0.44%
8	or product quality complaint	3	0.44%
9	event or product quality	3	0.44%
10	beyond the approved labeling	3	0.44%
11	report an adverse event	3	0.44%
12	an adverse event or	3	0.44%
13	hyaluronidase solution intuniv® guanfacine	2	0.29%
14	recombinant adynovate® antihemophilic factor	2	0.29%
15	factor recombinant adynovate® antihemophilic	2	0.29%
16	recombinant pegylated adzynma adamts13	2	0.29%
17	solution intuniv® guanfacine kalbitor®	2	0.29%
18	product cii advate® antihemophilic	2	0.29%
19	amphetamine product cii advate®	2	0.29%
20	the use of any	2	0.29%
21	von willebrand factor recombinant	2	0.29%
22	pegylated adzynma adamts13 recombinantkrhn	2	0.29%
23	human with recombinant human	2	0.29%
24	agrylin® anagrelide hydrochloride amitiza®	2	0.29%
25	a singleentity amphetamine product	2	0.29%
26	takeda does not recommend	2	0.29%
27	10 human with recombinant	2	0.29%
28	infusion 10 human with	2	0.29%
29	aralast® np alpha1proteinase inhibitor	2	0.29%
30	np alpha1proteinase inhibitor human	2	0.29%
31	alpha1proteinase inhibitor human carbatrol®	2	0.29%
32	globulin infusion 10 human	2	0.29%
33	and drug administration fda	2	0.29%
34	food and drug administration	2	0.29%
35	anagrelide hydrochloride amitiza® lubiprostone	2	0.29%
36	adderall xr® mixed salts	2	0.29%
37	of a singleentity amphetamine	2	0.29%
38	all fields are required	2	0.29%
39	sd® immune globulin intravenous	2	0.29%
40	and enter keywords to	2	0.29%

EXTERNAL LINKS

#	URL	Whois	Check
1	https://www.takeda.com/privacy-notice/	Whois	takeda.com
2	https://www.takeda.com/en-us/terms-of-use/	Whois	takeda.com
3	https://www.takeda.com/en-us/	Whois	takeda.com
4	http://globalmedical.takeda.com	Whois	takeda.com
5	https://www.oncologymedinfo.com/	Whois	oncologymedinfo.com